Lipella Pharmaceuticals Inc. Common Stock (LIPO) financials · rev $536.4K
Lipella Pharmaceuticals Inc. Common Stock (LIPO) rev $536.4K.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $536.4K | $449.6K |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$5.1M | -$4.7M |
| Net Income | -$5.0M | -$4.6M |
| EPS (Diluted) | $-4.79 | $-0.77 |
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Total Assets | $2.7M | $3.6M | $6.0M | $2.0M |
| Current Assets | $2.6M | $3.4M | $5.8M | $1.8M |
| Cash & Equivalents | $2.2M | $3.3M | $5.1M | $1.4M |
| Inventory | $0 | $0 | $0 | $0 |
| PP&E | $9.9K | $12.8K | $0 | $0 |
| Total Liabilities | $754.4K | $432.7K | $1.3M | $589.3K |
| Current Liabilities | $754.4K | $385.4K | $1.2M | $340.6K |
| Short-term Debt | $0 | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 | $0 |
| Shareholders' Equity | $1.9M | $3.1M | $4.7M | $1.4M |
| Retained Earnings | -$15.3M | -$10.3M | -$5.7M | -$3.1M |
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$4.0M | -$3.2M |
| CapEx | $0 | $14.4K |
| Investing Cash Flow | $0 | -$14.4K |
| Financing Cash Flow | $2.8M | $1.3M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $0 | $0 |
| Free Cash Flow | $0 | -$3.2M |
FAQ
What is LIPO P/E and revenue?
Lipella Pharmaceuticals Inc. Common Stock (LIPO) rev $536.4K.
What is LIPO revenue?
Lipella Pharmaceuticals Inc. Common Stock last cached revenue is $536.4K (FY2024).
Is LIPO profitable?
Lipella Pharmaceuticals Inc. Common Stock last cached net income is -$5.0M.
What are LIPO total assets?
Lipella Pharmaceuticals Inc. Common Stock last cached total assets are $2.7M.
What is LIPO free cash flow?
Lipella Pharmaceuticals Inc. Common Stock last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.